SCHEMBL2456912

SCHEMBL2456912

Cc1nnc(C)c(-c2cc[nH]n2)c1-c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.41
MAP3K14 Q99558 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
RPA1 P27694 1/20 0.35
METAP2 P50579 1/20 0.35
NOTUM Q6P988 1/20 0.35
MAPT P10636 9/20 0.34
NPSR1 Q6W5P4 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
ALOX12 P18054 2/20 0.34
CYP2C19 P33261 2/20 0.34
GPR55 Q9Y2T6 2/20 0.34
MAPK1 P28482 2/20 0.34
HTT P42858 2/20 0.34
ALPL P05186 1/20 0.34
GYS1 P13807 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645103 0.77 METAP2 (0.50) MEN1KMT2ARPA1METAP2NOTUM
Methylamine SCHEMBL27885520 0.75 METAP2 (0.46) IKBKBMAP3K14MEN1KMT2ARPA1
Hydrochloric Acid SCHEMBL10565482 0.75 METAP2 (0.48) MEN1KMT2ARPA1METAP2NOTUM
SCHEMBL4764742 0.73 POLB (0.53) MAPTNPSR1MAPK1KDM4ETDP1
SCHEMBL2456914 0.72 AKT1 (0.51) MEN1KMT2A
SCHEMBL2455752 0.71 MEN1 (0.44) IKBKBMAP3K14MEN1KMT2AMAPT
SCHEMBL28822256 0.69 LTA4H (0.51) MEN1KMT2AMETAP2NOTUMMAPT
SCHEMBL2453925 0.68 MEN1 (0.42) IKBKBMAP3K14MEN1KMT2AMAPT
SCHEMBL2456950 0.68 MEN1 (0.42) IKBKBMAP3K14MEN1KMT2AMAPT
SCHEMBL13165378 0.68 APEX1 (0.48) MEN1KMT2AKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1958948-B1 PYRIDAZINE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2011-10-05 EP disclosed
US-8022073-B2 Substituted pyridazine compounds and fungicidal uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-20 US disclosed
US-20090156608-A1 Pyridazine Compound and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-18 US disclosed
EP-1958948-A1 PYRIDAZINE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156608-A1 Pyridazine Compound and Use Thereof PLPBP, PNPO, PDXK IKBKB 2953/4885MAP3K14 1151/4885MEN1 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.